Premium
India’s diagnostics sector has always been a sweet spot for investors and gained further traction from private equity players during the Covid-19 pandemic. Temasek- and Motilal Oswal PE-backed Molbio Diagnostics is no different. Molbio attained a valuation of $1.6 billion last year when Temasek led an $85-million (around Rs 680 crore) ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
